Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q2 FY19 results · Jul–Sep 2018
Dr. Lal Path Labs reported revenue from operations of ₹317.50 crore and net profit of ₹57.40 crore for Q2 FY19 (Jul–Sep 2018), on a consolidated basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 317.50 | — | — | 292.30 | +8.6% |
| Other income | 10.90 | — | — | 9.40 | +16.0% |
| Total income | 328.40 | — | — | 301.70 | +8.8% |
| Profit before tax | 88.10 | — | — | 75.40 | +16.8% |
| Net profit for the period | 57.40 | — | — | 49.70 | +15.5% |
| Attributable to shareholders of the company | 57.00 | — | — | 49.40 | +15.4% |
| EPS, basic (₹) | 6.92 | — | — | 6.00 | +15.3% |
| Net margin (%) | 18.1 | — | 17.0 |
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 307.20 | — | — | 282.90 | +8.6% |
| Other income | 10.70 | — | — | 10.90 | −1.8% |
| Total income | 317.90 | — | — | 293.80 | +8.2% |
| Profit before tax | 84.80 | — | — | 74.90 | +13.2% |
| Net profit for the period | 55.20 | — | — | 49.80 | +10.8% |
| EPS, basic (₹) | 6.71 | — | — | 6.05 | +10.9% |
| Net margin (%) | 18.0 | — | 17.6 |
Consolidated
- Filed with BSE
- 06 Nov 2018, 18:32 IST
- Board meeting
- 06 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Nov 2018, 18:32 IST
- Board meeting
- 06 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE